FDA.reportPublic FDA data

Application 019668

Type
NDA
Sponsor
PFIZER

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CARDURADOXAZOSIN MESYLATETABLET;ORALEQ 1MG BASEYesYes
002CARDURADOXAZOSIN MESYLATETABLET;ORALEQ 2MG BASEYesNo
003CARDURADOXAZOSIN MESYLATETABLET;ORALEQ 4MG BASEYesNo
004CARDURADOXAZOSIN MESYLATETABLET;ORALEQ 8MG BASEYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0049-2410CarduradoxazosinRoerigNDACurrent
0049-2410CarduradoxazosinRoerigNDACurrent
0049-2410CarduradoxazosinRoerigNDACurrent
0049-2512CarduradoxazosinRoerigNDACurrent
0049-2512CarduradoxazosinRoerigNDACurrent
0049-2512CarduradoxazosinRoerigNDACurrent
0049-2614CarduradoxazosinRoerigNDACurrent
0049-2614CarduradoxazosinRoerigNDACurrent
0049-2614CarduradoxazosinRoerigNDACurrent
0049-2750Carduradoxazosin mesylateRoerigNDACurrent
0049-2750Carduradoxazosin mesylateRoerigNDACurrent
0049-2750Carduradoxazosin mesylateRoerigNDACurrent
0049-2750Carduradoxazosin mesylateRoerigNDACurrent
0049-2750Carduradoxazosin mesylateRoerigNDACurrent
0049-2750Carduradoxazosin mesylateRoerigNDACurrent
0049-2750Carduradoxazosin mesylateRoerigNDACurrent
0049-2750Carduradoxazosin mesylateRoerigNDACurrent
0049-2760Carduradoxazosin mesylateRoerigNDACurrent
0049-2760Carduradoxazosin mesylateRoerigNDACurrent
0049-2760Carduradoxazosin mesylateRoerigNDACurrent
0049-2760Carduradoxazosin mesylateRoerigNDACurrent
0049-2760Carduradoxazosin mesylateRoerigNDACurrent
0049-2760Carduradoxazosin mesylateRoerigNDACurrent
0049-2760Carduradoxazosin mesylateRoerigNDACurrent
0049-2760Carduradoxazosin mesylateRoerigNDACurrent
0049-2770Carduradoxazosin mesylateRoerigNDACurrent
0049-2770Carduradoxazosin mesylateRoerigNDACurrent
0049-2770Carduradoxazosin mesylateRoerigNDACurrent
0049-2770Carduradoxazosin mesylateRoerigNDACurrent
0049-2770Carduradoxazosin mesylateRoerigNDACurrent
0049-2770Carduradoxazosin mesylateRoerigNDACurrent
0049-2770Carduradoxazosin mesylateRoerigNDACurrent
0049-2770Carduradoxazosin mesylateRoerigNDACurrent
0049-2780Carduradoxazosin mesylateRoerigNDACurrent
0049-2780Carduradoxazosin mesylateRoerigNDACurrent
0049-2780Carduradoxazosin mesylateRoerigNDACurrent
0049-2780Carduradoxazosin mesylateRoerigNDACurrent
0049-2780Carduradoxazosin mesylateRoerigNDACurrent
0049-2780Carduradoxazosin mesylateRoerigNDACurrent
0049-2780Carduradoxazosin mesylateRoerigNDACurrent
0049-2780Carduradoxazosin mesylateRoerigNDACurrent
59762-2310Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2310Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2310Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2310Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-2310Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2310Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2310Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2310Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-2310Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2320Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2320Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2320Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2320Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2320Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-2320Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2320Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2320Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2320Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-2340Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-2340Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2340Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2340Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2340Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-2340Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2340Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2340Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2340Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2380Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2380Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2380Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2380Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2380Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-2380Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2380Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2380Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-2380Doxazosin mesylatedoxazosin mesylateGreenstone LLCNDACurrent
59762-2410DoxazosindoxazosinGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-2410DoxazosindoxazosinGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-2410DoxazosindoxazosinGreenstone LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
68463SUPPL2021-08-25
67895SUPPL2021-06-24
11617SUPPL2016-06-13
1482SUPPL2016-06-10
11615SUPPL2015-08-24
11616SUPPL2013-11-08
17541SUPPL2013-11-07
17540SUPPL2010-03-10
33850SUPPL2009-07-23
17539SUPPL2009-07-17
1481SUPPL2006-03-03
17538SUPPL2003-06-22
1480SUPPL2002-01-23